Carlsmed, Inc.

CARL·NasdaqGS·Healthcare
Compare
16.09+1.69 (+11.74%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.40
Open14.77
Day range14.7716.22
52-week range8.5017.23
Off day high−0.80%
Off 52-week high−6.62%
Volume90.82K
Avg. volume (3M)108.17K
Market cap439.30M
EPS (TTM)-1.08
Forward P/E-11.66
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding27.30M
Short interest10.71% of float
Earnings dateNov 10, 2026
Analyst target19.40
Profit margin−57.42%

Against its peers

Compare in full ›
CARL DRIO AIML.CN 3733.T ACARIX.ST OFIX
Market cap 439.30M 29.10M 13.43M 52.33B 206.92M 392.90M
P/E (TTM) — — — 10.5 — —
Forward P/E -11.7 -2.7 — 10.4 — 26.3
Price/book 5.2 0.4 -6.4 1.4 4.8 0.9
Dividend yield — — — 1.47% — —
1-year change +35.32% −75.41% 0.00% −17.79% −33.90% −33.79%
Today +11.74% −1.00% −10.00% −0.69% −7.23% +10.96%

The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.

Latest news

All CARL news ›
StreetInsider.com·Positive

Carlsmed launches lumbar spine system at NASS annual meeting

Carlsmed, Inc. (Nasdaq: CARL) announced the U.S. commercial launch of its aprevo® Lumbar Bi-lateral Posterior System at the North American Spine Society's 41st Annual Meeting in San Antonio, Texas. The launch follows a limited market…

MarketBeat·Positive

Carlsmed (NASDAQ:CARL) Price Target Raised to $24.00

Carlsmed (NASDAQ:CARL - Get Free Report) had its target price boosted by stock analysts at BTIG Research from $23.00 to $24.00 in a research report issued on Monday, Benzinga reports. The firm presently has a "buy" rating on the stock.…

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance